Date Field | Doc. No. | Party | Description |
---|
Nov 22, 2023 | 1 | petitioner | Notice : Petitioner's Power of Attorney Download |
Nov 22, 2023 | 1001 | petitioner | EX-1001 - U.S. Patent 10.961,307 Download |
Nov 22, 2023 | 1002 | petitioner | Ex-1002-Declaration of Alan Victor Safdi Download |
Nov 22, 2023 | 1003 | petitioner | Download |
Nov 22, 2023 | 1004 | petitioner | EX-1004 - 2017.02.25 Internet Archives - Stelara label 761044lbl Download |
Nov 22, 2023 | 1005 | petitioner | EX-1005 - Updated Ochsenkuhn JCC Abstract Download |
Nov 22, 2023 | 1006 | petitioner | EX-1006 - Vedolizumab label Entyvio_VMB245 R1_FULL INFORMATION_300 mg_2014 Download |
Nov 22, 2023 | 1007 | petitioner | EX-1007 - Adalimumab label Humira Download |
Nov 22, 2023 | 1008 | petitioner | Download |
Nov 22, 2023 | 1009 | petitioner | EX-1009 - Danese & Fiocchi, Ulcerative Colitis, N Engl J Med., 365:1713- 25 Download |
Nov 22, 2023 | 1010 | petitioner | Download |
Nov 22, 2023 | 1011 | petitioner | Exhibit 1011 - Ahern et al., Interleukin-23 Drives Intestinal Inflammation. Download |
Nov 22, 2023 | 1012 | petitioner | EX-1012 - Uhlig et al., Differential Activity of IL-12 and IL-23... Download |
Nov 22, 2023 | 1013 | petitioner | EX-1013 - Yen et al., IL-23 is essential for T cell-mediated colitis and... Download |
Nov 22, 2023 | 1014 | petitioner | EX-1014 - Aggeletopoulou et al., Interleukin 12/interleukin 23 pathway... Download |
Nov 22, 2023 | 1015 | petitioner | EX-1015 - Pedersen et al., Inflammatory pathways of importance for... Download |
Nov 22, 2023 | 1016 | petitioner | EX-1016 - Coskun et al., Novel Targeted Therapies for Inflammatory Bowel... Download |
Nov 22, 2023 | 1017 | petitioner | EX-1017 - Sandborn et al., A Randomized Trial of Ustekinumab... Download |
Nov 22, 2023 | 1018 | petitioner | EX-1018 - U.S. Patent No. 6,902,734 B2 issued to Giles-Komar et al. Download |
Nov 22, 2023 | 1019 | petitioner | EX-1019 - U.S. Patent No. 7,166,285 B2 issued to Giles-Komar et al. Download |
Nov 22, 2023 | 1020 | petitioner | EX-1020c -Application for Extension re U.S. Patent 6,902,734 (part 3 of 3) Download |
Nov 22, 2023 | 1020 | petitioner | EX-1020b -Application for Extension re U.S. Patent 6,902,734 (part 2 of 3) Download |
Nov 22, 2023 | 1020 | petitioner | EX-1020a -Application for Extension re U.S. Patent 6,902,734 (part 1 of 3) Download |
Nov 22, 2023 | 1021 | petitioner | EX-1021 -Application for Extension of Patent Term for U.S. Patent 7,166,285 Download |
Nov 22, 2023 | 1022 | petitioner | Download |
Nov 22, 2023 | 1023 | petitioner | EX-1023 - Webarchive screenshots of www.pmda.go.jp/english/index.html Download |
Nov 22, 2023 | 1024 | petitioner | EX-1024 - Stelara Prescribing Information (Sept. 2009) Download |
Nov 22, 2023 | 1025 | petitioner | Download |
Nov 22, 2023 | 1026 | petitioner | EX-1026 - Feagan et al., Ustekinumab as Induction and Maintenance Therapy. Download |
Nov 22, 2023 | 1027 | petitioner | EX-1027 - Janssen R & D NCT02407236 Clinical Protocol (Apr. 20, 2016) Download |
Nov 22, 2023 | 1028 | petitioner | EX-1028 - Affidavit of Nathaniel E Frank-White Download |
Nov 22, 2023 | 1029 | petitioner | EX-1029 -Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry Download |
Nov 22, 2023 | 1030 | petitioner | EX-1030 -Field Trials of Health Interventions: A Toolbox, 2015, pp. 200-201 Download |
Nov 22, 2023 | 1031 | petitioner | EX-1031 - Sands et al., Ustekinumab as Induction and Maintenance Therapy... Download |
Nov 22, 2023 | 1032 | petitioner | EX-1032 - Janssen Announces U.S. FDA Approval of STELARA (ustekinumab)... Download |
Nov 22, 2023 | 1033 | petitioner | EX-1033 - Tarr et al., Superheroes in autoimmune warfare: Biologic... Download |
Nov 22, 2023 | 1034 | petitioner | EX-1034 - Kolios et al., Paradoxical ulcerative colitis during adalimumab.. Download |
Nov 22, 2023 | 1035 | petitioner | EX-1035 - Afonso et al., CP-202 Ustekinumab treatment in refractory... Download |
Nov 22, 2023 | 1036 | petitioner | EX-1036a - Excerpts from U.S. Patent 10,961,307 file history (1 of 2) Download |
Nov 22, 2023 | 1036 | petitioner | EX-1036b - Excerpts from U.S. Patent 10,961,307 file history (2 of 2) Download |
Nov 22, 2023 | 1038 | petitioner | EX-1038 - FDA Approves STELARA (Ustekinumab) for Treatment... (9/26/2016) Download |
Nov 22, 2023 | 1041 | petitioner | EX-1041 - American of College of Rheumatology: Ustekinumab (Stelara) (2018) Download |
Nov 22, 2023 | 1042 | petitioner | Download |
Nov 22, 2023 | 1043 | petitioner | EX-1043 - Dhanda et al., Can Endoscopy Be Avoided in the Assessment... Download |
Nov 22, 2023 | 1044 | petitioner | EX-1044 - Glossary of Common Site Terms, ClinicalTrials.gov (Oct. 2021) Download |
Nov 22, 2023 | 1045 | petitioner | EX-1045 - Outcome Measure Considerations for Clinical Trials Reporting... Download |
Nov 22, 2023 | 1046 | petitioner | EX-1046 - History of Changes for Study: NCT02407236, ClinicalTrials.gov Download |
Nov 22, 2023 | 1047 | petitioner | EX-1047 - History of Changes for Study 2: NCT02407236, ClinicalTrials.gov Download |
Nov 22, 2023 | 1048 | petitioner | EX-1048 - Kim et al., Correlation between Histological Activity... Download |
Nov 22, 2023 | 1049 | petitioner | EX-1049a -U.S. Patent Application Publication 2020/0262908 A1 (part 1 of 2) Download |
Nov 22, 2023 | 1049 | petitioner | EX-1049b -U.S. Patent Application Publication 2020/0262908 A1 (part 2 of 2) Download |
Nov 22, 2023 | 1050 | petitioner | EX-1050 - Pithadia & Jain, Treatment of inflammatory bowel disease (IBD) Download |
Nov 22, 2023 | 1051 | petitioner | EX-1051 - Higgins et al., Is Endoscopy Necessary for the Measurement... Download |
Nov 22, 2023 | 1052 | petitioner | Download |
Nov 22, 2023 | 1052 | petitioner | Download |
Nov 22, 2023 | 1053 | petitioner | Download |
Nov 22, 2023 | 1054 | petitioner | EX-1054 - History of Changes for Study: NCT02407236, ClinicalTrials.gov Download |
Nov 22, 2023 | 1055 | petitioner | EX-1055 - Stelara, European Medicines Agency Download |
Nov 22, 2023 | 1056 | petitioner | EX-1056 - Nakov et al., Correlation between Ulcerative Colitis Endoscopic Download |
Nov 22, 2023 | 1060 | petitioner | EX-1060 - A Safety and Efficacy Study for Infliximab (Remicade) in Patients Download |
Nov 22, 2023 | 1061 | petitioner | EX-1061 - Efficacy and Safety of Adalimumab in Subjects With Moderately... Download |
Nov 22, 2023 | 1062 | petitioner | EX-1062 - Study of Vedolizumab (MLN0002) in Patients With Moderate to... Download |
Nov 22, 2023 | 1063 | petitioner | EX-1063 - Sequence published with WO 2015/119841 A1 issued to Zuniga et al. Download |
Nov 22, 2023 | 1064 | petitioner | EX-1064 - A Study to Evaluate the Safety and Efficacy of Ustekinumab... Download |
Nov 22, 2023 | 1065 | petitioner | EX-1065 - webarchive of Chemical Database for Ustekinumab Download |
Nov 22, 2023 | 1066 | petitioner | EX-1066 - webarchive of Label: STELARA - ustekinumab injection, solution Download |
Nov 22, 2023 | 1067 | petitioner | EX-1067 - Webarchive of Label: STELARA - ustekinumab injection, solution Download |
Nov 22, 2023 | 1068 | petitioner | EX-1068 - Labeling Archives, search results for ustekinumab - 2016 STELARA Download |
Nov 22, 2023 | 1069 | petitioner | EX-1069 STELARA- ustekinumab solution Archived Drug Label )Sept. 2016) Download |
Nov 22, 2023 | 1070 | petitioner | EX-1070 - Ustekinumab (Stelara), Ottawa (ON): Canadian Agency for Drugs... Download |
Nov 22, 2023 | 1071 | petitioner | EX-1071 - Declaration of Noah S. Frank Download |
Nov 22, 2023 | 1072 | petitioner | EX-1072 - Listing of Challenged Claims of the 10,961,307 patent Download |
Nov 22, 2023 | 2 | petitioner | IPR Petition (307) Download |
Nov 28, 2023 | 3 | board | Notice: Notice filing date accorded Download |
Dec 13, 2023 | 4 | patent_owner | Notice : Power of Attorney Download |
Dec 13, 2023 | 5 | patent_owner | Patent Owner's Mandatory Notices Download |
Jan 8, 2024 | 2001 | patent_owner | Ex. 2001 Decl. of Roger J. Chin iso PHV Admission Download |
Jan 8, 2024 | 6 | patent_owner | Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Roger J. Chin Download |
Jan 8, 2024 | 7 | patent_owner | Patent Owner's Exhibit List Download |
Jan 16, 2024 | 8 | board | Download |
Jan 18, 2024 | 9 | patent_owner | Patent Owner's Updated Mandatory Notices Download |
Feb 28, 2024 | 3001 | board | Exhibit 3001 Download |
Mar 1, 2024 | 10 | petitioner | Joint Motion to Terminate Proceeding Download |
Mar 1, 2024 | 11 | petitioner | Joint Motion to Treat Settlement Agreement as Business Confidential Download |
Mar 1, 2024 | 0 | petitioner | Joint Motion to Terminate Proceeding Download |
Mar 4, 2024 | 12 | board | Termination Decision: Pre-DI settlement Download |
Apr 11, 2024 | 13 | petitioner | Petitioner's Request for Refund of Post-Institution Fees Download |
Apr 15, 2024 | 14 | board | Notice: refund approved Download |